Table 1. Patient characteristics for sequencing.
| Characteristic | uLMCAD (n=5) | Non-CAD (n=5) | P value |
|---|---|---|---|
| Age(years), mean ± SD | 56.00±5.43 | 57.00±6.89 | 0.805 |
| Male gender, n (%) | 4 [80] | 2 [40] | 0.197 |
| Hypertension, n (%) | 2 [40] | 1 [20] | 0.490 |
| DM, n (%) | 0 [0] | 0 [0] | 1.000 |
| History of MI, n (%) | 1 [20] | 0 [0] | 0.292 |
| HDL (mmol/L), mean ± SD | 0.96±0.13 | 1.27±0.05 | 0.003* |
| LDL (mmol/L), mean ± SD | 3.11±2.36 | 2.84±0.51 | 0.863 |
| TC (mmol/L), mean ± SD | 1.65±0.56 | 1.61±0.70 | 0.931 |
| Past smoker, n (%) | 3 [60] | 0 [0] | 0.038* |
| Medication | |||
| CCB, n (%) | 4 [80] | 1 [20] | 0.058 |
*, P<0.05 for comparison between two groups. Patient characteristics were compared in patients with uLMCAD and non-CAD controls. DM, diabetes mellitus; CHD, coronary heart disease; MI, myocardial infarction; HDL, high density lipoprotein; LDL, low density lipoprotein; TC, total cholesterol; CCB, calcium channel blockers.